Corporate Board Profile
Tech Score: 0/100
Filing Date | Source Excerpt |
---|---|
2017-04-21 | Dr. Hove is an appropriate member of the Companys Board of Directors, given his extensive training and experience as a medical doctor and masters of business administration, an executive in the pharmaceutical industry, and as an investor in biotechnology companies. |
2018-04-18 | Dr. Hove has an M.Sc. in Biotechnology Engineering, an M.D., and an M.B.A., but no mention of computer science or programming skills. |
2018-09-20 | Anders Hove, M.D. is listed as a director, no software-related skills or programming experience mentioned. |
2019-10-25 | He received a M.Sc. in Biotechnology Engineering from the Technical University of Denmark, an M.D. from the University of Copenhagen and an M.B.A. from the Institut Européen d'Administration des Affaires. He has experience as a medical doctor, pharmaceutical executive, and investor. |
2020-10-28 | He received a M.Sc. in Biotechnology Engineering from the Technical University of Denmark, an M.D. from the University of Copenhagen and an M.B.A. from the Institut Européen d'Administration des Affaires. We believe Dr. Hove is an appropriate member of the Company’s Board of Directors, given his extensive training and experience as a medical doctor and masters of business administration, an executive in the pharmaceutical industry, and as an investor in biotechnology companies. |
2021-04-21 | He received a M.Sc. in Biotechnology Engineering from the Technical University of Denmark, an M.D. from the University of Copenhagen and an M.B.A. from the Institut Européen d'Administration des Affaires. We believe Dr. Hove is an appropriate member of the Company’s Board of Directors, given his extensive training and experience as a medical doctor and masters of business administration, an executive in the pharmaceutical industry, and as an investor in biotechnology companies. |
2022-11-03 | Dr. Hove received a M.Sc. in Biotechnology Engineering from the Technical University of Denmark, an M.D. from the University of Copenhagen and an M.B.A. from the Institut Européen d'Administration des Affaires. He has experience as an executive in the pharmaceutical industry and as an investor in biotechnology companies. |
2023-12-19 | He received a M.Sc. in Biotechnology Engineering from the Technical University of Denmark, an M.D. from the University of Copenhagen and an M.B.A. from INSEAD. We believe Dr. Hove is an appropriate member of the Board of Directors, given his extensive training and experience as a medical doctor and masters of business administration, an executive in the pharmaceutical industry, and as an investor in biotechnology companies. |
Data sourced from SEC filings. Last updated: 2025-10-11